| Lipid apheresis group | Control group | p-value* |
---|---|---|---|
 | (n=32 arteries) | (n=32 arteries) |  |
Lumen Area | 15.9 ± 6.3 | 13.0 ± 7.6 | ns |
[mm2, Minimum] | |||
Wall Area | 49.7 ± 11.8 | 59.6 ± 21.6 | 0.03 |
[mm2, Maximum] | |||
Normalized Wall Index | 0.61 ± 0.09 | 0.72 ± 0.12 | <0.001 |
[Maximum] | |||
Outer Wall Area | 105.4 ± 28.3 | 102.0 ± 35.4 | ns |
[mm2, Maximum] | |||
Plaque Components (quantitative) | |||
Necrotic Lipid Core | 5.0 ± 9.4 | 11.6 ± 13.4 | 0.025 |
[% of Vessel Wall, Maximum] | |||
Intraplaque Hemorrhage | 2.1 ± 8.8 | 2.3 ± 6.8 | ns |
[% of Vessel Wall, Maximum] | |||
Calcifications | 4.8 ± 6.0 | 5.3 ± 6.1 | ns |
[% of Vessel Wall, Maximum] | |||
Prevalence of Plaque Components | |||
Necrotic Lipid Core [%] | 28.1 | 56.3 | 0.025 |
Intraplaque Hemorrhage [%] | 9.4 | 15.6 | ns |
Calcifications [%] | 53.1 | 56.3 | ns |
American Heart Association (AHA) Lesion Type | |||
Type I [%] | 15.6 | 12.5 | ns |
Type III [%] | 25.0 | 15.6 | ns |
Type IV/V [%] | 13.0 | 37.5 | 0.023 |
Type VI [%] | 9.4 | 15.6 | ns |
Type VII [%] | 37.5 | 18.8 | ns |
Type VIII [%] | 0 | 0 | ns |